ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW - Regular Plan

Other Plans and Options
  • (-0.7%)Nav, as on 22-07-2025

  • Previous Nav

  • Net Change on 22-07-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option 4.48 8.74 19.39 28.67 24.29 21.93
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option Jul 13, 2018 19.39 28.67 24.29 1.89 5,727.59
NIPPON INDIA PHARMA FUND - IDCW Option Jun 05, 2004 11.89 23.95 21.68 1.80 8,569.15
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jul 03, 1999 19.18 27.86 23.93 1.93 3,849.24
DSP Healthcare Fund - Regular Plan - IDCW Nov 30, 2018 12.69 25.36 22.68 1.93 3,056.90
Mirae Asset Healthcare Fund Regular IDCW Jul 02, 2018 13.84 22.90 22.04 1.93 2,785.12
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option Dec 28, 2015 11.18 23.56 21.85 2.11 1,281.99

Fund Holdings as on 30-June-2025

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Cipla Ltd.

  • Aurobindo Pharma Ltd.

  • Biocon Ltd.

  • Mankind Pharma Ltd

  • Alkem Laboratories Ltd.

  • Lupin Ltd.

  • Gland Pharma Ltd.

  • Zydus Lifesciences Ltd.

  • TREPS

  • Syngene International Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Pfizer Ltd.

  • Shilpa Medicare Ltd.

  • Medplus Health Services Ltd

  • Sagility India Ltd

  • Advanced Enzyme Technologies Ltd.

  • Medi Assist Healthcare Services Ltd

  • Windlas Biotech Ltd.

  • Metropolis Healthcare Ltd.

  • Thyrocare Technologies Ltd.

  • Fine Organic Industries Ltd.

  • Aarti Drugs Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • Yatharth Hospital & Trauma Care Services Pvt Ltd

  • Star Health & Allied Insurance

  • Sanofi Consumer Healthcare India Ltd

  • FDC Ltd.

  • Astrazeneca Pharma India Ltd.

  • Net Current Assets

  • Procter & Gamble Health Ltd.

  • Sun Pharma Advanced Research Co. Ltd

  • Senores Pharmaceuticals Ltd

  • Unichem Laboratories Ltd.

  • Cash Margin - Derivatives

View More

  • Pharmaceuticals & Drugs

  • Business Support

  • Hospital & Healthcare Services

  • Miscellaneous

  • Chemicals

  • Insurance

View More

Most Recent Dividend

  • 07/08/2024

  • 16/08/2023

  • 12/08/2022

  • 13/08/2021

  • 06/08/2020

  • Cash

  • Equity

View More

About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund

Scheme Analysis

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ICICI Prudential Mutual Fund. It was launched on 13-Jul-2018 and currently has an AUM of ₹5,727.59 crore. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund ended down ₹-0.18(-0.7%)yesterday to ₹25.64.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is managed by Dharmesh Kakkad .

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100